找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Dermato-Oncology Study Guide; Essential Text and R Vincent Liu Textbook 2021 Springer Nature Switzerland AG 2021 Dermato-oncology.Paraneopl

[復(fù)制鏈接]
樓主: 撒謊
41#
發(fā)表于 2025-3-28 15:30:12 | 只看該作者
Complementary and Alternative Medicine and Dermatooncology,ctually causing harm. In this chapter we will explore alternate treatments to avoid, those with potential benefits in prevention and treatment of cutaneous malignancy, and those with potential benefits in treating non-oncologic cutaneous problems.
42#
發(fā)表于 2025-3-28 19:50:33 | 只看該作者
Textbook 2021 intersection of skin and malignancy. In it, there is clinical detail provided on how the skin reveals systemic malignancy via cutaneous metastases, genodermatoses or paraneoplastic dermatoses. At the same time, it reviews pharmacologic treatment of internal malignancy and how this can result in cut
43#
發(fā)表于 2025-3-28 23:28:40 | 只看該作者
Cutaneous Metastases,ed management of the underlying malignancy. Cutaneous metastases are infrequent and may clinically mimic primary neoplastic and non-neoplastic skin disorders; thus, familiarity with the full range of their clinical and pathological presentations is critical to recognition. Patterns of metastasis bas
44#
發(fā)表于 2025-3-29 03:13:37 | 只看該作者
Paraneoplastic Dermatoses and Related Conditions,syndromes occur in upwards of 15% of cancer patients, and skin is the second most commonly targeted organ system. Paraneoplastic dermatoses vary considerably in their prevalence and strength of association with characteristic underlying malignancy. Division of dermatoses suspected as paraneoplastic
45#
發(fā)表于 2025-3-29 10:24:00 | 只看該作者
46#
發(fā)表于 2025-3-29 15:15:32 | 只看該作者
47#
發(fā)表于 2025-3-29 18:33:57 | 只看該作者
48#
發(fā)表于 2025-3-29 22:54:29 | 只看該作者
Dermatologic Adverse Effects of Anticancer Therapy I: General Principles,nticancer therapy. Reviewed are strategies and protocols for treating common symptoms and conditions experienced by these patients. Specific anticancer therapeutic classes are addressed in greater detail in the following three chapters.
49#
發(fā)表于 2025-3-30 03:30:12 | 只看該作者
Dermatologic Adverse Effects of Anticancer Therapy II: Cytotoxic Agents,w of indications for each drug class as well as profiles of their potential mucocutaneous reactions. For each anticancer agent, a clinical summary is provided, offering an a overview of incidence, natural course, clinical features, and management of its dermatologic adverse effects. This chapter is
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 13:24
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
德安县| 太原市| 大余县| 新密市| 普洱| 山丹县| 土默特右旗| 乡城县| 紫阳县| 溆浦县| 潼南县| 麻城市| 浠水县| 云南省| 陆良县| 绍兴县| 朝阳市| 广南县| 乐至县| 龙门县| 邛崃市| 嘉祥县| 应城市| 奉节县| 永嘉县| 托克托县| 上虞市| 确山县| 民县| 迭部县| 牡丹江市| 苍山县| 观塘区| 济宁市| 沾化县| 邯郸市| 许昌市| 桃江县| 郑州市| 安塞县| 丘北县|